期刊文献+

阿尔茨海默病与轻度认知障碍患者的营养状况分析 被引量:10

Nutritional analysis of patients with alzheimer's disease and mild cognitive impairnent
原文传递
导出
摘要 目的探讨营养因素对阿尔茨海默病(AD)认知障碍进展的影响。方法采用病例对照研究,选择轻中度AD52例、轻度认知障碍(MCI)51例,相匹配的正常人群55例为对照组。所有研究对象均填写一般情况量表、营养调查表;测评MMSE、ADL量表。测量身高、体重,计算体质量指数,测定血清叶酸、维生素B12等指标水平。结果 AD的体质量指数(20.33±5.07)明显低于MCI(23.54±4.42)、对照组(24.68±4.36)(P<0.05),其他营养指标均无统计学差异;AD组叶酸、VitB12水平[(17.5±5.3)nmol/L,(302.3±210.5)pmol/L]明显低于MCI[(23.3±6.7)nmol/L,(399.6±197.8)pmol/L]及对照组[(24.2±5.4)nmol/L,(421.8±235.4)pmol/L](P<0.05);AD和MCI组的血清叶酸、Vit B12水平均与MMSE、ADL评分无相关性(P>0.05)。结论 AD患者存在身体营养障碍,其中体质量指数较敏感;AD患者存在叶酸、维生素B12水平的下降,但血清叶酸、维生素B12水平与AD的严重程度无关。 Objective To determine the influence of nutritional factors on the cognitive disorder progress during alzheimer diseaes.Methods 52 moderate and mild AD,51 mild cognition impaired patients and 55 controls were evaluated by general scale,mini-nutritional assessment scale,MMSE and ADL scale.Height,weight,body mass index(BMI),serum folic acid and vitamin B12 were measured.Results The BMI of AD(20.33±5.07) was significantly lower than those of MCI(23.54±4.42) and controls(24.68±4.36)(P〈0.05).The serum folic acid and vitamin B12 of AD [(17.5±5.3)nmol/L,(302.3±210.5)pmol/L] were obviously lower than those of MCI [(23.3±6.7)nmol/L,(399.6±197.8)pmol/L] and controls [(24.2±5.4)nmol/L,(421.8±235.4)pmol/L](P〈0.05).There was no significant association between MMSE,ADL scale and serum folic acid and vitamin B12 level of AD MCI groups(P〈0.05).Conclusions Impaired nutritions(BMI,mini-nutritional assessment scale,serum folic acid and vitamin B12) commonly exist in patients with AD,moreover,BMI is more sensitive for AD.Serum folic acid and vitamin B12 are lower in the AD group,however,there are no association between serum folic acid,vitamin B12 level and severity of AD.
出处 《卒中与神经疾病》 2010年第4期217-219,共3页 Stroke and Nervous Diseases
基金 国家青年自然科学基金(30900473) 上海市科委重点支持计划(08411950700)(08411950700) 上海市科委重大课题(09DZ1950400)
关键词 阿尔茨海默病 营养 叶酸 维生素B12 Alzheimer′s disease Nutrition Folic acid Vitamin B12
  • 相关文献

参考文献12

  • 1Guigoz Y,Vallas BJ,Garry PJ.Assessing the nutritional status of the elderly:the mini nutritional assessment as part of the geriatric evaluation.Nutr Rev,1996,54(1-2):59-65.
  • 2Spaccavento S,Del Prete M,Craca A,et al.Influence of nutritional status on congnitive,functional and neuropsychiatric deficits in Alzheimer's disease.Arch Gerontol Geriatr,2009,48(3):356-360.
  • 3Smith KL,Greenwood CE.Weight loss and nutritional considerations in Alzheimer disease.J Nutr Elder,2008,27(3-4):381-403.
  • 4Sitburana O,Rountree S,Ondo WG.Weight change in Parkinson and Alzheimer patients taking atypical antipsychotic drugs.J Neurol Sci,2008,272 (1-2):77-82.
  • 5Shatenstein B,Kergoat MJ,Reid I,et al.Dietary intervention in older adults with early-stage Alzheimer dementia:early lessons learned.J Nutr Health Aging,2008,12(7):461-469.
  • 6Selley ML,Close DR,Stem SE.The effect of increased concentrations of homocysteine on the concentration of(E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease.Neurobiol Aging,2002,23(3):383-388.
  • 7王春玉,钱采韻,方莹莹.Alzheimer病血清胆固醇、血脂、叶酸、VB_(12)及甲状腺激素变化的临床研究[J].中国老年学杂志,2006,26(7):873-875. 被引量:18
  • 8Kronenberg G,Colla M,Endres M.Folic acid,neurodegenerative and neuropsychiatric disease.Curr Mol Med,2009,9(3):315-323.
  • 9Serol JM.Christmann D,Dubost T,et al.CSF folate levels are decreased in late onset AD patients.J Neural Transm,2001,108(1):93-99.
  • 10Aisen PS,Schneider LS,Sano M,et al.High-dose B vitamin supplementation and cognitive decline in Alzheimer disease:a randomized controlled trial.JAMA,2008,300(15):1774-1783.

二级参考文献19

  • 1Jick H,Zornberg GL,Jick SS,et al.Statins and the risk of dementia[J].Lancet,2000;356(9242):1627-31.
  • 2Kivipelto M,Helkala EL,Hanninen T,et al.Midlife vascular risk factors and late-life mild cognitive impairment:a population-based study[J].Neurology,2001;56(12):1683-9.
  • 3Whyte E,Mulsant BH,Butters MA,et al.Cognitive and behavioral correlates of low vitamin B12 levels in elderly patients with progressive dementia[J].Am J Geriatr Psychiatry,2002;10:321-7
  • 4Eastley R,Wilcock GK,Bucks RS.Vitamin B12 deficiency in dementia and cognitive impairment:the effects of treatment on neuropsychological function[J].Int J Geriatr Psychiatry,2000;15:226-33.
  • 5Leblhuber F,Walli J,Artner-Dworzak E,et al.Hyperhomocysteinemia in dementia[J].J Neural Transm,2000;107:1469-74.
  • 6Cutler RG,Kelly J,Storie K,et al.Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease[J].Proc Natl Acad Sci USA,2004;101(7):2070-5.
  • 7Refolo LM,Pappolla MA,LaFrancois J,et al.A cholesterol-lowering drug reduces-β-amyloid pathology in a transgenic mouse model of Alzheimer's disease[J].Neurobiol Dis,2001;8(5):890-9.
  • 8Simons M,Keller P,De Strooper B,et al.Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons[J].Proc Natl Acad Sci USA,1998;95(11):6460-4.
  • 9Refolo LM,Malester B,LaFrancois J,et al.Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model[J].Neurobiol Dis,2000;7(4):321-31.
  • 10Kojro E,Gimpl G,Lammich S,et al.Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM10[J].Proc Natl Acad Sci USA,2001;98(10):5315-20.

共引文献17

同被引文献136

引证文献10

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部